Exilam Beta Tablet
By Exilam Beta
Rx
10 Tablet in a Strip

Composition
Etizolam(0.5mg) + Propranolol(20mg)

Manufacturer - ADN Life Sciences
1203 Rajsarover, Off Link Road, Borivali West, Borivali West, Mumbai-400068, Maharashtra, India

Expires on or after
September, 2025

liver
If you have a history of liver disease or conditions, it is important to be cautious when using Exilam Beta Tablet. Patients with liver issues may require dose adjustments for safe and effective use of this medication. It is recommended to consult your doctor before starting Exilam Beta Tablet to determine the appropriate dosage. Regular monitoring of blood pressure is also advised to help in dose adjustment if needed.

kidney
Limited information is available regarding the use of Exilam Beta Tablet in patients with kidney disease. Please consult your doctor. Use with caution if you have a history of kidney diseases/conditions. Dose adjustments may be needed as recommended by your doctor.

alcohol
Avoid drinking alcohol while taking Exilam Beta Tablet to prevent drowsiness and other negative effects.

driving
When using Exilam Beta Tablet, be careful while driving. Side effects like visual disturbances, fatigue, and dizziness can affect your ability to drive safely. Avoid driving if you experience drowsiness, double vision, or any vision issues after taking Exilam Beta Tablet.

pregnancy
Exilam Beta Tablet may not be safe during pregnancy. Limited human studies show potential harm to the baby. Animal studies also indicate risks. Your doctor will assess benefits and risks before prescribing. Consult your doctor. Betapro-ET 0.5mg Tablet 10's is rated as a Category C pregnancy drug, with safety information being unknown. If pregnant or planning pregnancy, consult your doctor.

breastfeeding
It is better to consult your doctor before using Exilam Beta Tablet.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹133.4
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024